image

28.3.3 NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines®) for Systemic Light Chain Amyloidosis V.1.2019

Chapter 28.3.3

The Guidelines developed by the National Comprehensive Cancer Network® (NCCN®) on the management of AL amyloidosis patients state that SPE, sIFE and uIFE should be performed in all patients with suspected AL amyloidosis [1211]. Additionally, they recognise sFLC analysis as a complementary test to the above mentioned methods.

References

    • 1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Systemic Light Chain Amyloidosis V.1.2019 © National Comprehensive Cancer Network, Inc. 2018. All rights reserved. Accessed [12/12/2018]. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.